InsidersTradesSigma
Moberg Pharma AB (publ): insider trades · Finland · FIN-FSA
FI:moberg-pharma-ab-publ-ef5183SE0003613090FI·FIN-FSAMcap 503M€Healthcare
Discover the full directors' dealings record of Moberg Pharma AB (publ), a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Moberg Pharma AB (publ) has recorded 3 insider filings. Market capitalisation: €502.9m. The latest transaction was disclosed on 24 November 2025 — Purchase. Among the most active insiders: Richard Ding. All data is openly available.
3
Insider Decl.
0
Thresholds
€2,790
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
10.70 €
Analyst consensus
1 analystsStrong buy
14.00 €Target 14.00 €(+31%)14.00 €
Income statement
Revenue13.5 M€
Gross profit7.7 M€57% margin
Net income−27.2 M€-201.2% margin
Valuation
PER (forward)53.5x
P/Book0.5x
Beta0.64
Balance sheet & cash
Market cap502.9 M€
Total debt2.5 M€
Free Cash Flow−60.7 M€
Debt / Equity2%
Profitability & ownership
% insiders12.1%
% institutions21.7%
Last declaration on 24 November 2025
Declarations3 total
Executives●Purchase22FIN-FSA
€7461,000 shares@ €0.74630.0001% mcap26.8% of flow
Aktie
FI:A003U081-1·
Ideal exit: 18 Aug 2026 (T+270)
Executives●Purchase23FIN-FSA
€1,2221,600 shares@ €0.76370.0002% mcap43.8% of flow
Aktie
FI:A003U065-1·
Ideal exit: 16 Aug 2026 (T+270)
Executives●Purchase15FIN-FSA
€8211,000 shares@ €0.82150.0002% mcap29.4% of flow
Aktie
FI:A003T733-1·
Ideal exit: 11 Aug 2026 (T+270)
3 of 3 declarations